Biomerica Inc. (NASDAQ: BMRA) Gains 23.90% YTD: What’s Next? – Marketing Sentinel
Home  »  Business   »  Biomerica Inc. (NASDAQ: BMRA) Gains 23.90% YTD: Wh...

Biomerica Inc. (NASDAQ: BMRA) Gains 23.90% YTD: What’s Next?

Biomerica Inc. (NASDAQ:BMRA)’s traded shares stood at 1.54 million during the last session, with the company’s beta value hitting -0.67. At the close of trading, the stock’s price was $6.17, to imply a decrease of -6.66% or -$0.44 in intraday trading. The BMRA share’s 52-week high remains $8.15, putting it -32.09% down since that peak but still an impressive 46.52% since price per share fell to its 52-week low of $3.30. The company has a valuation of $55.96M, with an average of 16.73 million shares in intraday trading volume over the past 10 days and average of 1.91 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Biomerica Inc. (BMRA), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give BMRA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.12.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Biomerica Inc. (NASDAQ:BMRA) trade information

After registering a -6.66% downside in the last session, Biomerica Inc. (BMRA) has traded red over the past five days. The stock hit a weekly high of 7.38 this Thursday, 10/07/21, dropping -6.66% in its intraday price action. The 5-day price performance for the stock is 37.11%, and 41.84% over 30 days. With these gigs, the year-to-date price performance is 23.90%. Short interest in Biomerica Inc. (NASDAQ:BMRA) saw shorts transact 0.97 million shares and set a 15.3 days time to cover.

Analysts on Wall Street suggest a consensus price target of $13.00, implying an increase of 52.54% to the stock’s current value. The extremes give us $13.00 and $13.00 for target low and target high price respectively. As such, BMRA has been trading -110.7% off suggested target high and -110.7% from its likely low.

Biomerica Inc. (BMRA) estimates and forecasts

Looking at statistics comparing Biomerica Inc. share performance against respective industry, we note that the company has underperformed competitors. Biomerica Inc. (BMRA) shares are 14.90% up over the last 6 months, with its year-to-date growth rate lower than industry average at 9.26% against 17.50%. Revenue is forecast to grow 14.30% this quarter before jumping 7.70% for the next one. The rating firms project that company’s revenue will grow 17.80% compared to the previous financial year.

Revenue forecast for the current quarter as set by 1 analysts is $1.9 million. Meanwhile, for the quarter ending Nov 2021, a total of 1 analyst(s) estimate revenue growth to $2.05 million.

BMRA Dividends

Biomerica Inc. has its next earnings report out between October 13 and October 18. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Biomerica Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Biomerica Inc. (NASDAQ:BMRA)’s Major holders

Biomerica Inc. insiders hold 16.01% of total outstanding shares, with institutional holders owning 20.52% of the shares at 24.43% float percentage. In total, 20.52% institutions holds shares in the company, led by Granahan Investment Management Inc. As of Jun 29, 2021, the company held over 1.03 million shares (or 8.22% of shares), all amounting to roughly $4.12 million.

The next major institution holding the largest number of shares is Vanguard Group, Inc. (The) with 0.58 million shares, or about 4.65% of shares outstanding. As of the market price on Jun 29, 2021, these shares were worth $2.33 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Biomerica Inc. (BMRA) shares. Going by data provided on Jun 29, 2021, JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd holds roughly 0.61 million shares. This is just over 4.87% of the total shares, with a market valuation of $2.44 million. Data from the same date shows that the other fund manager holds a little less at 0.41 million, or 3.25% of the shares, all valued at about 1.63 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam